Aditxt, Inc. Conversion of Stock, Shares Converted
Aditxt, Inc. (ADTX) reported Conversion of Stock, Shares Converted of 61 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2025-03-31
- Aditxt, Inc. conversion of stock, shares converted for the quarter ending 2024-12-31 was -15.19K shares.
- Aditxt, Inc. conversion of stock, shares converted for the quarter ending 2024-09-30 was -594.75K shares.
- Aditxt, Inc. conversion of stock, shares converted for the quarter ending 2024-06-30 was 0.00 shares.
- Aditxt, Inc. conversion of stock, shares converted for the quarter ending 2024-03-31 was 610.00K shares.
- Aditxt, Inc. conversion of stock, shares converted for fiscal 2024 was 61.00 shares, a 99.99% decline from fiscal 2023.
- Aditxt, Inc. conversion of stock, shares converted for fiscal 2023 was 610.00K shares.
| Period end | Conversion of Stock, Shares Converted 1 month | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | -15.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -609.94K shares derived: sum of 2 quarters · filed 2025-03-31 | -609.94K shares derived: sum of 3 quarters · filed 2025-03-31 | 61.00 shares 10-K · filed 2025-03-31 | |
| 2024-09-30 | -594.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | -594.75K shares derived: sum of 2 quarters · filed 2024-11-18 | 15.25K shares 10-Q · filed 2024-11-18 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | 610.00K shares 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | 610.00K shares 10-Q · filed 2024-05-20 | ||||
| 2023-12-31 | 610.00K shares 10-K · filed 2024-04-16 | ||||
| 2021-08-30 | 1.01M shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |